Clinical Trial Update: AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation [Phase 2]

View source ↗

Summary

Alcon Research completed a Phase 2 clinical trial evaluating AL-38583 Ophthalmic Solution for allergic conjunctivitis with inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AL-38583 Ophthalmic Solution

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED